Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions

被引：49
|
作者：
Maldi, Elena [1 ]
Travelli, Cristina [2 ]
Caldarelli, Antonio [2 ]
Agazzone, Nicolo [2 ]
Cintura, Sara [2 ]
Galli, Ubaldina [2 ]
Scatolini, Maria [3 ]
Ostano, Paola [3 ]
Miglino, Benedetta [2 ]
Chiorino, Giovanna [3 ]
Boldorini, Renzo [1 ]
Genazzani, Armando A. [2 ]
机构：
[1] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy
[2] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy
[3] Fondo Edo Tempia, Lab Canc Genom, Biella, Italy
来源：
PIGMENT CELL & MELANOMA RESEARCH | 2013年 / 26卷 / 01期
关键词：
D O I：
10.1111/pcmr.12037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 146
页数：3
相关论文
共 50 条
  • [1] Nicotinamide phosphoribosyl transferase (NAMPT) is over-expressed in Melanoma
    Travelli, Cristina
    Maldi, Elena
    Galli, Ubaldina
    Tron, GianCesare
    Boldorini, Renzo
    Genazzani, Armando
    CANCER RESEARCH, 2012, 72
  • [2] Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma becoming a potential biomarker
    Fiorilla, I.
    Mazzola, F.
    Todesco, A. M.
    Moiso, E.
    Piacente, F.
    Ponzano, A.
    Libener, R.
    Grosso, F.
    Bruzzone, S.
    Raffaelli, N.
    Audrito, V.
    FEBS OPEN BIO, 2024, 14 : 301 - 302
  • [3] Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)
    Audrito, Valentina
    Manago, Antonella
    Gaudino, Federica
    Deaglio, Silvia
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 98 : 192 - 201
  • [4] Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
    Audrito, Valentina
    Manago, Antonella
    La Vecchia, Sofia
    Zamporlini, Federica
    Vitale, Nicoletta
    Baroni, Gianna
    Cignetto, Simona
    Serra, Sara
    Bologna, Cinzia
    Stingi, Aureliano
    Arruga, Francesca
    Vaisitti, Tiziana
    Massi, Daniela
    Mandala, Mario
    Raffaelli, Nadia
    Deaglio, Silvia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (03):
  • [5] Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
    Grolla, Ambra A.
    Torretta, Simone
    Gnemmi, Ilaria
    Amoruso, Angela
    Orsomando, Giuseppe
    Gatti, Marco
    Caldarelli, Antonio
    Lim, Dmitry
    Penengo, Lorenza
    Brunelleschi, Sandra
    Genazzani, Armando A.
    Travelli, Cristina
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (06) : 718 - 729
  • [6] IS NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) THE MARKER FOR OSTEOBLAST DIFFERENTIATION?
    He, X.
    He, J.
    Lin, L.
    Zhang, L.
    Li, Y.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S578 - S578
  • [7] Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
    Galli, Ubaldina
    Travelli, Cristina
    Massarotti, Alberto
    Fakhfouri, Gohar
    Rahimian, Reza
    Tron, Gian Cesare
    Genazzani, Armando A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (16) : 6279 - 6296
  • [8] Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
    Sampath, Deepak
    Zabka, Tanja S.
    Misner, Dinah L.
    O'Brien, Thomas
    Dragovich, Peter S.
    PHARMACOLOGY & THERAPEUTICS, 2015, 151 : 16 - 31
  • [9] Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
    Velma, Ganga Reddy
    Krider, Isabella S.
    Alves, Erick T. M.
    Courey, Jenna M.
    Laham, Megan S.
    Thatcher, Gregory R. J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 5999 - 6026
  • [10] Nicotinamide phosphoribosyltransferase (NAMPT): a new cytokine in tumor progression
    Grolla, Ambra
    Torretta, Simone
    Amoruso, Anpla
    Orsomando, Giuseppe
    Genazzani, Armando
    CANCER RESEARCH, 2015, 75
12345